Join us on 11 December to discover how SYNTHIA accelerates retrosynthesis by helping chemists design, compare and refine routes with customisable filters and commercial building blocks

Event details and registration

Register now

The advent of artificial intelligence has allowed for massive breakthroughs in the field of chemistry. One of which is in chemical synthesis and retrosynthetic analysis – the process of breaking down a target molecule into its constituent starting materials. Artificial intelligence can speed up this process and identify novel synthetic pathways that may not be initially obvious, allowing for revolutionary advances in fields including drug development and discovery, chemical manufacturing and academic research.

This is where SYNTHIA Retrosynthesis Software excels. This webinar will guide chemists through the end-to-end workflow of SYNTHIA, from selecting a target and customising search options to filtering results and identifying commercial building blocks. We will discuss what makes SYNTHIA unique as a retrosynthesis software and how it has been applied to real-world examples. Attendees will leave with practical tactics to speed up route scouting and improve outcomes in discovery and process chemistry.

During this session, you will learn about topics including:

  • How SYNTHIA can accelerate route planning by identifying multiple synthetic routes from readily available starting materials
  • How to use SYNTHIA’s customisation features to build routes based on a specific target and project needs
  • How SYNTHIA can support greener chemistry by avoiding hazardous reagents and finding alternatives.

Emma Gardener

Portrait of Emma Gardener, technical applications manager, digital chemistry at Merck KGaA

Emma is the technical applications manager for digital chemistry supporting the commercial licensing of SYNTHIA retrosynthesis software. She earned a PhD from Brown University, US, where she focused on the synthesis of antibacterial peptide natural products and worked in the biotech industry prior to joining Merck KGaA in 2018.

 

Angelo Lanzilotto

Portrait of Angelo Lanzilotto, solution sales specialist, digital chemistry at Merck KGaA

Angelo received a PhD in chemistry from the University in Basel, Switzerland. Moved to Amgen in Canada to work on antibody discovery and later to Selvita working on lead optimisation of small molecule drugs. In 2021, joined Merck KGaA and is now in the Digital Chemistry division, where we develop and commercialise drug discovery software and automation.

Event details and registration

Register now